-
A novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient
Study
EGAS00001002840
-
Colorectal adenomas, carcinomas and adjacent normal NKI-AvL TGO series NGS-ProToCol
Study
EGAS00001002854
-
Clonal fitness inferred from timeseries modeling of single cell cancer genomes
Study
EGAS00001004448
-
Versatile workflow for cell-type resolved transcriptional and epigenetic profiles from cryopreserved human lung
Study
EGAS00001004477
-
Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses
Study
EGAS00001002967
-
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Study
EGAS00001005340
-
Open_Targets_020_Epigenomes_of_Cell_Lines
Study
EGAS00001003137
-
Open_Targets_020_Epigenomes_of_Cell_Lines
Study
EGAS00001003139
-
Healthy_ageing_thymus
Study
EGAS00001004311
-
Novel optineurin frameshift insertion causing familial frontotemporal dementia and parkinsonism without amyotrophic lateral sclerosis
Study
EGAS00001005220
-
Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes
Study
EGAS00001005906
-
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients
Study
EGAS00001004491
-
Butyrate producers as potential next-generation probiotics: safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers
Study
EGAS00001003276
-
Transcriptomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum
Study
EGAS00001004668
-
Exome sequencing
Study
EGAS00001005761
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
RaScALL: Rapid screening of RNA-seq in acute lymphoblastic leukaemia
Study
EGAS00001006460
-
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma
Study
EGAS00001003746
-
Colorectal cancer study
Study
EGAS00001006489
-
Robust methylation-based classification of brain tumours using nanopore sequencing
Study
EGAS00001006540
-
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO-trial
Study
EGAS00001006902
-
Chronic lymphocytic leukemia IGHV somatic hypermutation detection by targeted capture next-generation sequencing
Study
EGAS00001006887
-
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Study
EGAS00001007029
-
Treatment stratification and biomarker validation using patient-derived head and neck cancer organoids
Study
EGAS00001007076
-
A Machine Learning Tool Integrating Circulating Cell-Free DNA Methylation with Clinical Variables for Non-Invasive Diagnosis of Liver Graft Pathology
Study
EGAS00001007171
-
scRNAseq for patients with immunodeficiency and HCs
Study
EGAS00001007271
-
Analysis of the Elements Involved in the Enrichment of a Panel of Genomic Regions by Nanopore Sequencing Using Adaptive Sampling
Study
EGAS00001007375
-
Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency
Study
EGAS00001007393
-
shallow WGS and deep targeted panel on ctDNA in rhabdomyosarcomas
Study
EGAS00001007399
-
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
Study
EGAS00001007501
-
Peripheral blood DNA methylome in adalimumab-treated patients with rheumatoid arthritis
Study
EGAS00001007578
-
Pharmacogenomic Analysis Reveals New Therapeutic Options for Pleural Mesothelioma
Study
EGAS00001007866
-
Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoids
Study
EGAS00001008227
-
Immunodeficiency syndrome caused by LCP1 mutations
Study
EGAS00001008293
-
Gut metagenome from Estonian Microbiome Cohort
Dataset
EGAD00001008448
-
Myeloma Genome Project Targeted Panel Validation dataset
Dataset
EGAD00001008689
-
Clonal selection after gene therapy in sickle cell disease
Dataset
EGAD00001010913
-
RNAseq data for Failure of Differentiation of the Rhombic Lip Constitutes Medulloblastoma
Dataset
EGAD00001008458
-
KiCS WGS data for academic and for-profit use
Dataset
EGAD00001009699
-
Irish Covid19 WGS Alignment Data
Dataset
EGAD00001010098
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma
Study
EGAS00001006001
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Whole_genome_sequencing_of_100_DDD_trios_with_suspected_noncoding_causal_mutations
Study
EGAS00001002452
-
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600 mutated melanoma
Study
EGAS00001007709
-
Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients
Study
EGAS50000000334
-
METABRIC
Study
EGAS00000000098
-
Cell-Free DNA Genomic and Fragmentomic Features for Early Outcome Prediction in Diffuse Large B-Cell Lymphoma
Study
EGAS50000000412
-
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Study
EGAS50000000710
-
Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer
Study
EGAS00001007716
-
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification and exhaustion in multiple myeloma
Study
EGAS50000000304
-
Discovery and validation of an ancillary genomic test of malignancy for primary melanocytic tumors
Study
EGAS50000000887
-
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia
Study
EGAS50000000933
-
Bladder cancer subtyping study across 4 atezo clinical trials
Study
EGAS50000000497
-
The phase II Neo-Pembro trial: neoadjuvant pembrolizumab in stage IV high-grade serous ovarian cancer
Study
EGAS50000000781
-
Analysis of CD20 loss in patients treated with Mosunetuzumab
Study
EGAS50000000151
-
Repeat expansions with small TTTCA insertions in MARCHF6 cause Familial Adult Myoclonus without Epilepsy
Study
EGAS50000000570
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
Convergent evolution towards CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Study
EGAS50000000709
-
IDH-wildtype untreated human glioblastoma samples (GB-UK cohort), published in Noorani & Haughey et al 2025.
Study
EGAS00001008126
-
RNAseq: Acquired non-permissive bone marrow microenvironment impairs hematopoietic stem cell proliferation and maintenance and B-cell development post-HSCT
Study
EGAS50000001437
-
ATAC-seq: Acquired non-permissive bone marrow microenvironment impairs hematopoietic stem cell proliferation and maintenance and B-cell development post-HSCT
Study
EGAS50000001438
-
Single-cell Transcriptome Profiling of Treatment-naïve and Post-treatment Colorectal Cancer: Insights into Putative Mechanisms of Chemoresistance
Study
EGAS50000000830
-
Development and validation of multivariate predictors of primary endocrine resistance to tamoxifen and aromatase inhibitors in luminal breast cancer reveal drug-specific differences
Study
EGAS50000001102
-
Biallelic variants in the non-protein coding minor spliceosome components RNU6ATAC and RNU6ATAC cause syndromic monogenic autoimmune diabetes
Study
EGAS50000001565
-
Confronting historical legacies of biological anthropology in South Africa—Restitution, redress and community-centered science: The Sutherland Nine
Study
EGAS50000000971
-
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial
Study
EGAS50000001572
-
Distinct evolutionary trajectories of primary high grade serous ovarian cancers revealed through spatial mutational profiling
Study
EGAS00001000547
-
PCGP Ph-like ALL
Study
EGAS00001000654
-
Dynamics of genomic clones in breast cancer patient xenografts at single cell resolution
Study
EGAS00001000952
-
UK10K NEURO FSZ
Study
EGAS00001000118
-
Molecular_diagnosis_of_albinism
Study
EGAS00001002068
-
Whole-exome Sequencing Combined with Functional Genomics Reveals Novel Candidate Driver Cancer Genes in Endometrial Cancer
Study
EGAS00001000318
-
Integrative genomic profiling of hepatocellular adenomas reveals recurrent FRK activating mutations and mutational processes of malignant transformation
Study
EGAS00001000679
-
Systems biology of Colorectal Cancer
Study
EGAS00001000854
-
The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
Study
EGAS00001001305
-
MiR expression profiles of paired primary colorectal cancerand metastases by next-generation sequencing
Study
EGAS00001001127
-
Genesis of Two Most Prevalent Variants Causing Combined Pituitary Hormone Deficiency in 21 Populations
Study
EGAS00001001165
-
'Targeted High Throughput Sequencing in Clinical Cancer Settings: Formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity'
Study
EGAS00001000136
-
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Study
EGAS00001001308
-
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia (CML)
Study
EGAS00001001751
-
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
Study
EGAS00001002102
-
Targeting the DNA Repair Pathway in Ewing Sarcoma
Study
EGAS00001000839
-
The Genetic Landscape of BCL2 Break Negative Follicular Lymphoma
Study
EGAS00001002164
-
Molecular evolution of metastatic clear cell renal cell carcinoma progressing under tyrosine kinase inhibitor therapy (HIPO-045)
Study
EGAS00001001861
-
Whole genome and transcriptome analysis of a sporadic and recurring parathyroid carcinoma
Study
EGAS00001000484
-
Intra-tumor heterogeneity and clonal evolution patterns towards platinum-resistant high-grade serous ovarian cancer
Study
EGAS00001001244
-
Genome wide association study on coronary heart disease in patients with familial hypercholesterolemia
Study
EGAS00001000734
-
UK10K NEURO EDINBURGH
Study
EGAS00001000117
-
UK10K NEURO IMGSAC
Study
EGAS00001000120
-
Pharmacological and genomic profiling identifies NFκB-targeted treatment strategies for mantle cell lymphoma
Study
EGAS00001000622
-
Transcriptional_profiling_of_tauopathies_in_human_IPS_derived_neurons
Study
EGAS00001000382
-
Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing
Study
EGAS00001000962
-
Ischemic stroke in a Swedish case-control study.
Study
EGAS00001000936
-
Prenatal lead exposure is associated with decreased cord blood DNA methylation of the glycoprotein VI gene involved in platelet activation and thrombus formation
Study
EGAS00001001575
-
UK10K NEURO UKSCZ
Study
EGAS00001000123
-
Induced Pluripotent Cells Derived from Differentiated Rod Photoreceptors Undergo Efficient Retinogenesis in Three-Dimensional Cultures
Study
EGAS00001001288
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency
Study
EGAS00001000149
-
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Study
EGAS00001001601
-
Characterization of a human iPSC-derived endocrine pancreas model
Study
EGAS00001001803
-
Spiradenocarcinoma
Study
EGAS00001001799
-
panALL exome sequencing, data set2, 700 samples
Dataset
EGAD00001008268
-
WGS of cell-free DNA derived from plasma of patients with pediatric sarcoma and healthy controls, and lcWGS/RRBS of matched tumor tissue
Dataset
EGAD00001007080
-
A study of the genetic basis of evation by Acute Myeloid Leukaemia of Graft vs Leukaemia effects after allogeneic bone marrow transplantation
Dataset
EGAD00001000404
-
Targeted sequencing of genes recurrently mutated in AML
Dataset
EGAD00001000606
-
Genetic heritage of the Baphuthi highlights an over-ethnicised notion of 'Bushman' in the Maloti-Drakensberg, southern Africa
Study
EGAS00001007080
-
The University of Hong Kong Gastric Cancer Organoids RHO Signaling Study
Study
EGAS00001006252
-
DNA methylation-based prognostic subtypes of chordoma tumors in tissue
Study
EGAS00001006406
-
Genetic characterization of B-cell prolymphocytic leukemia: a hierarchical prognostic model involving MYC and TP53 abnormalities - RNA-seq
Study
EGAS00001003274
-
Integrative analysis of exome-seq, RNA-seq, ATAC-seq (bulk and single-cell), and Hi-C data generated from 3-D spatially mapped samples acquired during surgical resection from 10 patients diagnosed with IDH-WT glioblastoma
Study
EGAS00001006785
-
Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM
Study
EGAS00001007286
-
Ultra-fast deep-learned pediatric CNS tumor classification.
Study
EGAS00001007475
-
Transcriptomics-driven classification of ALAL
Study
EGAS00001007967
-
Limited Association between HRR Gene Alterations and HRD in Molecular Tumor Board Cancer Samples: Who should be tested for HRD?
Study
EGAS00001008063
-
Molecular subtypes of pancreatic neuroendocrine tumors mutated in MEN1/DAXX/ ATRX explain biological variability
Study
EGAS00001008272
-
A transcriptomic approach to understand patient susceptibility to pneumonia after abdominal surgery
Study
EGAS00001007229
-
Genomic and epigenomic characterization of juvenile myelomonocytic leukemia (JMML)
Study
EGAS00001002511
-
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
Study
EGAS00001005328
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations
Study
EGAS00001006034